Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-03T00:35:08.828Z Has data issue: false hasContentIssue false

Analysis of psychotropic drug advertising

Published online by Cambridge University Press:  02 January 2018

John Quinn*
Affiliation:
Mater Misericordiae Hospital, Dublin 7, Ireland
Marie Nangle
Affiliation:
Mater Misericordiae Hospital, Dublin 7, Ireland
Patricia R. Casey
Affiliation:
Mater Misericordiae Hospital, Dublin 7, Ireland
*
Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The use of metaphors as the main marketing strategy in psychotropic drug advertising in journals and the quality of information provided in these advertisements has been criticised. We investigated marketing strategies and information provision in advertisements appearing in three different psychiatric journals. The majority of advertisements in two of the journals used metaphors as their main marketing strategy. The level of prescribing information varied between journals. Our findings suggest that improvements are needed in psychotropic drug advertising in journals.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Avorn, J., Chen, M. & Hartley, R. (1982) Scientific versus commercial sources of influence on the prescribing behaviour of physicians. American Journal of Medicine, 73, 48.CrossRefGoogle ScholarPubMed
Dixon, T. (1993) Pharmaceutical advertising, information or influence? Canadian Family Physician, 39, 12981300.Google ScholarPubMed
Ferner, R. & Scott, D. (1994) Whatalotwegot – the messages in drug advertisements. British Medical Journal, 309, 17341736.Google Scholar
Goldman, R. & Montagne, M. (1986) Marketing ‘mind mechanics’: decoding antidepressant drug advertisements. Social Science and Medicine, 22, 10471058.Google Scholar
Hemminki, E. (1975) Review of literature on the factors affecting drug prescribing. Social Science and Medicine, 9, 111115.CrossRefGoogle ScholarPubMed
Herxheimer, A., Lundborg, C. & Westerholm, B. (1993) Advertisements for medicines in leading medical journals in 18 countries: a 12 month survey of information content and standards. International Journal of Health Services, 23, 161172.Google Scholar
Kleinman, D. & Cohen, L. (1991) The decontextualisation of mental illness: the portrayal of work in psychiatric drug advertisements. Social Science and Medicine, 32, 867874.Google Scholar
Lexchin, J. (1987) Pharmaceutical promotion in Canada: convince them or confuse them. International Journal of Health Services, 17, 7789.Google Scholar
Lion, J., Regan, B., Taylor, R., et al (1979) Psychiatrists' opinions of psychotropic drug advertisements. Social Science and Medicine, 13A, 123125.Google ScholarPubMed
Owen, J. (1992) Images used to sell psychotropic drugs. Psychiatric Bulletin, 16, 2526.Google Scholar
Riska, E. & Hagglund, U. (1991) Advertising for psychotropic drugs in the Nordic countries: metaphors, gender and life situations. Social Science and Medicine, 32, 465471.Google Scholar
Scott, D. & Ferner, R. (1994) The strategy of desire' and rational prescribing. British Journal of Clinical Pharmacology, 37, 217219.Google Scholar
Seidenberg, R. (1971) Drug advertising and perception of mental illness. Mental Hygiene, 55, 2131.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.